Approval · Notice of Compliance 30010 · 2023
FLECAINIDE: Notice of Compliance 30010
Issued January 30, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30010
- Date
- January 30, 2023
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Companies
- Canadian reference product
- FLECAINIDE (AA Pharma Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLECAINIDE | 02534800 | Marketed |
| FLECAINIDE | 02534819 | Marketed |
Medicinal ingredients
- FLECAINIDE ACETATE 50 MG per TAB
- FLECAINIDE ACETATE 100 MG per TAB